Agomelatine: an agent against anhedonia and abulia? - Wikidata - awgldk - TriplyDB

Agomelatine: an agent against anhedonia and abulia?

Agomelatine: an agent against anhedonia and abulia?

http://www.wikidata.org/entity/Q38169108

about

Efficacy and tolerability of agomelatine in the treatment of depression Suicide in stroke survivors: epidemiology and prevention.Advances in antidepressants for treating post-stroke depression.

P2860

Q33583450-437D7DD3-F342-43E1-B0ED-3F4F1AC979BB Q38285840-413CDC04-0245-4544-A04A-A33EDD75815C Q39324538-7FFD64AB-1C23-4956-A8C4-177279E64A40

P2860

Agomelatine: an agent against anhedonia and abulia?

http://www.wikidata.org/entity/Q38169108

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Agomelatine: an agent against anhedonia and abulia?

@en

type

label

Agomelatine: an agent against anhedonia and abulia?

@en

prefLabel

Agomelatine: an agent against anhedonia and abulia?

@en

P1433

Q38169108-45CF8678-0CE6-43AB-866B-41D24982B810

P1476

Q38169108-69046956-09CB-44D4-AD3D-4587393415CC

P2093

Q38169108-0D631553-0CD0-4246-9C4C-347475C4633B

Q38169108-F6184133-CDFF-4A2C-B9E7-7FA77E078F2C

P2860

Q38169108-02299F54-9E1E-43EB-A173-BDDF79DC1F32

Q38169108-07AC0823-6736-484D-AADF-BB48AEF90C5D

Q38169108-1A78AAFB-AA7C-41CE-B449-51AF9AAD8E5D

Q38169108-32CFA78F-6552-4231-95F0-1BF054AC34E9

Q38169108-3FAEE550-B850-48A7-9F6E-C57AE62E620D

Q38169108-4458CB81-3EC8-4C16-9844-73373244D686

Q38169108-4533F108-2247-47B8-B8BA-EE44327920F6

Q38169108-45950DF7-8739-4E91-AF2F-DB0A1329D875

Q38169108-52833A81-0C76-4C46-82E1-57738B9B7AC6

Q38169108-5444771A-57EB-4847-936C-59E2BD6BF2C0

P2888

Q38169108-E0125FF2-F07D-4DF1-951B-0E64DC90DCF5

P304

Q38169108-ACA20C3B-6236-4ADB-A0CE-EC2A48EA6DD8

P31

Q38169108-8BC51D31-79C6-42CB-BEE7-EF41CAF08D58

P356

Q38169108-1CD777C9-97E1-45C3-B59A-D75F4438FCFB

P478

Q38169108-4537BE35-5F2A-4432-9A80-C89C09900EA5

P577

Q38169108-EB0561C2-1F4A-417F-AD26-AD575DF80C88

P698

Q38169108-3948B486-A035-4ECE-91CD-3884716C6D27

P356

S00702-013-1126-6

P1433

Journal of Neural Transmission

P1476

Agomelatine: an agent against anhedonia and abulia?

@en

P2093

J Thome

http://www.w3.org/2001/XMLSchema#string

P Foley

http://www.w3.org/2001/XMLSchema#string

P2860

Personalized medicine in major depressive disorder -- opportunities and pitfalls

Adjunctive agomelatine therapy in the treatment of acute bipolar II depression: a preliminary open label study

The novel melatonin agonist agomelatine (S20098) is an antagonist at 5-hydroxytryptamine2C receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways

Agomelatine in the treatment of major depressive disorder: potential for clinical effectiveness

A pooled analysis of six month comparative efficacy and tolerability in four randomized clinical trials: agomelatine versus escitalopram, fluoxetine, and sertraline

Efficacy of the novel antidepressant agomelatine for anxiety symptoms in major depression

Agomelatine efficacy and acceptability revisited: systematic review and meta-analysis of published and unpublished randomised trials

Treating organic abulia with bromocriptine and lisuride: four case studies.

Abulia: a delphi survey of British neurologists and psychiatrists.

Reconsidering anhedonia in depression: lessons from translational neuroscience.

P2888

s00702-013-1126-6

P304

S3-7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00702-013-1126-6

http://www.w3.org/2001/XMLSchema#string

P478

122 Suppl 1

http://www.w3.org/2001/XMLSchema#string

P577

2013-12-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24311062

http://www.w3.org/2001/XMLSchema#string